Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
240 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02066961 | A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer(ASPIRE-PCa) | completed | — | 1,533 | Astellas Pharma Global Development, Inc.INDUSTRY | 27 | Dec 20, 2019 | clinicaltrials |
| NCT03527628 | OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy((Optimist)) | unknown | Phase 2 | 220 | King Abdullah International Medical Research Center |
| 1 |
| Nov 18, 2019 |
| clinicaltrials |
| NCT04138342 | Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer | unknown | Phase 1 | 30 | Al-Azhar UniversityOTHER | 2 | Oct 24, 2019 | clinicaltrials |
| NCT03774680 | Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer | unknown | Phase 1 | 30 | Ahmed A. H. AbdellatifOTHER | 2 | Oct 10, 2019 | clinicaltrials |
| NCT02954471 | Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia | completed | — | 351 | Hoffmann-La RocheINDUSTRY | 1 | Sep 20, 2019 | clinicaltrials |
| NCT00191126 | Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC | completed | Phase 3 | 263 | Eli Lilly and CompanyINDUSTRY | 15 | Sep 12, 2019 | clinicaltrials |
| NCT02733809 | Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 4 | 40 | King Saud UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT00423735 | Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 3 | Jul 24, 2019 | clinicaltrials |
| NCT02304406 | Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa(ALK NSCLC MENA) | completed | — | 449 | PfizerINDUSTRY | 5 | Jul 19, 2019 | clinicaltrials |
| NCT01792726 | A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.(TARGIT-B) | unknown | N/A | 1,796 | University College, LondonOTHER | 12 | Jul 12, 2019 | clinicaltrials |
| NCT02281019 | SpyGlass AMEA Registry | completed | — | 526 | Boston Scientific CorporationINDUSTRY | 10 | Jul 10, 2019 | clinicaltrials |
| NCT00874211 | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | completed | — | 3,571 | SWOG Cancer Research NetworkNETWORK | 3 | Jul 5, 2019 | clinicaltrials |
| NCT01206764 | A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. | completed | Phase 4 | 143 | Novartis PharmaceuticalsINDUSTRY | 10 | Jun 24, 2019 | clinicaltrials |
| NCT00534729 | Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA | completed | N/A | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00534950 | Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck | completed | N/A | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00535041 | Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA | completed | N/A | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00535795 | Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA | completed | Phase 3 | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT01310985 | A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer | completed | — | 15 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT01488851 | Study to Assess Incidence of ONJ in Pts With Bone Mets Starting Zoledronic Acid Treatment | completed | — | 100 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT03762642 | Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients | completed | — | 335 | King Abdulaziz UniversityOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT00984282 | Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer | completed | Phase 3 | 417 | BayerINDUSTRY | 18 | Sep 13, 2018 | clinicaltrials |
| NCT03629847 | Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue | unknown | Phase 1 / Phase 2 | 30 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT02919878 | Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer | unknown | Phase 2 | 25 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT01310972 | Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX | completed | — | 6 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01530581 | Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation | completed | Phase 3 | 230 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | terminated | Phase 2 | 170 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT02919371 | Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) | unknown | Phase 1 / Phase 2 | 77 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT03090139 | Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets | completed | — | 1,731 | TakedaINDUSTRY | 10 | Jun 26, 2018 | clinicaltrials |
| NCT03398057 | Effect of Health Education on Female Teachers' Knowledge and Practices Regarding Early Breast Cancer Detection and Screening in the Jazan Area: A Quasi-Experimental Study | completed | N/A | 150 | Anwar Ali Ahmad AlameerOTHER_GOV | 1 | May 7, 2018 | clinicaltrials |
| NCT01137682 | Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly(PAOLA) | completed | Phase 3 | 198 | Novartis PharmaceuticalsINDUSTRY | 18 | Apr 5, 2018 | clinicaltrials |
| NCT01649856 | A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma | completed | Phase 3 | 572 | Hoffmann-La RocheINDUSTRY | 27 | Oct 11, 2017 | clinicaltrials |
| NCT02746432 | Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial | unknown | Phase 4 | 144 | King Saud UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02029573 | Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma(ART) | completed | Phase 2 | 36 | King Fahad Medical CityOTHER_GOV | 1 | Aug 18, 2017 | clinicaltrials |
| NCT00790036 | Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy(PILLAR2) | completed | Phase 3 | 742 | Novartis PharmaceuticalsINDUSTRY | 34 | Jul 12, 2017 | clinicaltrials |
| NCT01172548 | Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)(INV555) | completed | Phase 2 | 132 | Novartis PharmaceuticalsINDUSTRY | 12 | May 31, 2017 | clinicaltrials |
| NCT02086487 | Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy(NISRI) | terminated | Phase 4 | 98 | King Abdullah International Medical Research CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT02273856 | Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)(NADIR) | terminated | — | 25 | Astellas Pharma International B.V.INDUSTRY | 7 | Jun 21, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT02783885 | Clinical Utilization of Newly Approved Oncology Medications | unknown | — | 100 | National Guard Health AffairsOTHER_GOV | 1 | May 26, 2016 | clinicaltrials |
| NCT02781116 | Risk Assessment Tool in Saudi Arabia | unknown | — | 2,000 | National Guard Health AffairsOTHER_GOV | 1 | May 24, 2016 | clinicaltrials |
| NCT02775825 | Quality of the End of Life Care | completed | — | 180 | National Guard Health AffairsOTHER_GOV | 1 | May 19, 2016 | clinicaltrials |
| NCT02774915 | Outcome of Pregnancy and Breast Cancer(Pregnancy) | unknown | — | 20 | National Guard Health AffairsOTHER_GOV | 1 | May 17, 2016 | clinicaltrials |
| NCT01320488 | Breast Cancer in Young Women: Is it Different?(YoungWomen) | suspended | — | 600 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT01320501 | Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer(REALME) | suspended | Phase 4 | 100 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT01356303 | Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer(TAXIS01) | suspended | Phase 2 | 50 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT01356329 | Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients(Lovenox) | suspended | Phase 3 | 150 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT02062983 | Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients | suspended | — | 50 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT02729506 | Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | unknown | Phase 4 | 150 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Apr 6, 2016 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials